|Year : 2013 | Volume
| Issue : 3 | Page : 322-326
Immunomodulatory effect of ethanolic extract of Shirishadi compound
Divya Kajaria1, Jyoti Shankar Tripathi2, Shri Kant Tiwari3, Bajrangi Lal Pandey4
1 Assistant Professor, Department of Kayachikitsa, C.B.P.A.C.S, New Delhi, India
2 Associate Professor, Department of Kayachikitsa, IMS, BHU, Varanasi, Uttar Pradesh, India
3 Ex. Professor and Head, Department of Kayachikitsa, IMS, BHU, Varanasi, Uttar Pradesh, India
4 Professor and Head, Department of Pharmacology, IMS, BHU, Varanasi, Uttar Pradesh, India
|Date of Web Publication||17-Dec-2013|
Assistant Professor, Department of Kayachikitsa, C.B.P.A.C.S, New Delhi
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Immunomodulators are substances that helps to regulate the immune system. The basic mechanisms by which the herbs defend the body against infection have two probable ways- one by destroying pathogens and other by enhancing the body immunity. Shirishadi compound is a polyherbal drug used in Ayurvedic system of medicine for the management of allergic disorders such as allergic rhinitis, allergic asthma etc., The present study was carried out to evaluate the immunomodulatory activity of ethanolic extract of polyherbal compound "Shirishadi" on Swiss albino mice. Cyclophosphamide (CP) induced immunosuppression model was used to assess the activity of drug. CP was given in the dose of 30 mg/kg body weight through i.p route. 500 mg/kg body weight of Shirishadi polyherbal drug was given through oral route. The extent of protection against immunosuppression caused by CP was evaluated after 14 days of drug administration, by estimating hematological parameters and neutrophil adhesion test. Ethanolic extracts of Shirishadi compound showed pronounced immunoprotective activity by increasing the depleted levels of total WBC count and RBC, % Hb, and % neutrophils adhesion. The extract was found to be an effective immunomodulatory agent.
Keywords: Shirishadi compound, cyclophosphamide, immunomodulatory activity
|How to cite this article:|
Kajaria D, Tripathi JS, Tiwari SK, Pandey BL.
Immunomodulatory effect of ethanolic extract of Shirishadi compound. AYU 2013;34:322-6
| Introduction|| |
In recent years, there has been growing interest in the field of herbal medicines research and search for promising potential compounds for investigating the immunomodulatory compounds from natural products. The immune system is designed to protect the host from invading pathogens and to eliminate disease. Plants are the essential and integral part in Complementary and Alternative Medicine (CAM) and this is due to their ability to develop formation of secondary metabolites like proteins, flavonoids, alkaloids, steroids and phenolic substances, which are in turn used to restore health and heal many diseases. Herbal drugs are believed to enhance the natural resistance of the body against infection and their immunomodulatory activities have been reported in numerous plants. 
The concept of immunomodulation relates to nonspecific activation of the function and efficiency of macrophages, granulocytes, complement, natural killer cells and lymphocytes and also to the production of various effector molecules generated by activated cells. It is expected that theses nonspecific effects give protection against different pathogens including bacteria, viruses, fungi etc., and constitute an alternative to conventional chemotherapy.
The Polyherbal preparation used in present study contains Shirisha (Albezia lebbeck (L.) Benth, leguminosae), Nagarmotha (Cyperus rotundus Linn., Cyperaceae), and Kantakari (Solanum surattense, Mimosaceae). Albezia lebbeck reported to have anti-inflammatory, anti-anaphylactic effect, prevent mast cell degranulation and protect the sensitized guinea pig from antigen induced anoxic convulsion. ,, Previous researches shown that it is effective against bronchospasm induced by histamine acid phosphate and shown to exert di-sodium -cromoglycolate like action on mast cells. 
Kantakari (Solanum surattense) is one of the members of the Dashmula (ten roots) of the Ayurveda. A decoction of the root is given with the addition of long pepper and honey, in cough and catarrh, and with rock salt and asafoetida in spasmodic cough.  Plant has been investigated for much of responses and as well a pilot study on the clinical efficacy of Solanum surattense as a dried whole plant shown significant improvement in some respiratory diseases like bronchial asthma.  Cyperus rotundus is also found to have anti-inflammatory, anti-pyretic and analgesic activities along with antioxidant activity. ,,
Cyclophosphamide (CP) acts on both cyclic and intermitotic cells, resulting in general depletion of immunecompetent cells. CP is an alkylating agent widely used in anti-neoplastic therapy.  It is effective against a variety of cancers such as lymphoma, myeloma, and chronic lymphocytic leukemia. , CP induced immunosuppression is reported to prompt various types of infection. ,
The present study is aimed at investigating the immunomodulatory potency of the ethanol extract of Shirishadi Compound using Cyclophosphamide induced immunosuppression model by evaluating the effect of the extract on various hematological parameters and Neutrophil adhesion test in Swiss albino mice. 
| Materials and Methods|| |
The plants Albizia lebbeck (L.) Benth (Shirisha), Cyprus rotundus (Mustaka) and Solanum surattense (Kantakari) were collected from local market of Varanasi. The identification of the drugs was done by Department of Dravyaguna, S.S.U., Varanasi (Identification number DG/AKS/604).
Contents of Shirishadi compound are tabulated in [Table 1]
Extraction of the plant material and sample preparation
Hydroalcoholic Extraction (Distilled water: Ethanol = 2:1) of drug was carried out by hot percolation method through soxhlet apparatus. Thereafter the extract was dried using rotary evaporator and dried extract was put to the process of standardization. The percentage yield was noted.
| Drugs and Chemicals|| |
CP (Sigma, life science) was used as standard immunosuppressant. All the other reagents and chemicals used in studies were of analytical grade.
Eight week-old healthy, laboratory bred, Swiss albino mice of either sex (20-25 g) were maintained under standard laboratory conditions such as temperature 22-25°C, 12 h light/dark cycle and provided with water and pellet food ad libitum. The experiments were conducted as per the guidelines of Committee for the purpose of control and supervision of experiments on animals, India, Ministry of Social Justice and Empowerment, Government of India. The research protocol was approved by Institutional Research committee of Institute of Medical Sciences, BHU- India.
The ethanolic extract of polyherbal compound was subjected for evaluation of immunomodulatory activity using CP induced immunosuppression model and neutrophil adhesion test. 
Preparation of sample
The ethanolic extract of the plant were dissolved in distilled water and administered orally at a dose of 500 mg/kg b/w with the help of feeding cannula.
Preparation of cyclophosphamide
The CP was suspended in 0.5% Carboxy methyl cellulose (CMC) solution in distilled water. The solution was administered intraperitoneally at a dose of 30 mg/kg b/w.
Cyclophosphamide induced immunosuppression
The animals were divided into the 3 groups containing 6 animals in each Group 1 (Control group) received CMC for 14 days and group 2 (Challenge group) received CMC for 10 days, on 11 th , 12 th and 13 th day CP intraperitonially at a dose of 30 mg/kg b/w. Groups 3 (Test group) received ethanolic extract of the drug at a dose of 500 mg/kg body weight orally for 14 days. On days 11, 12 and 13 th day CP solution was given intraperitonially at a dose of 30 mg/kg b/w one hour after the administration of the extract.  This experimental study was a part of a clinical study in which the anti-asthmatic effect of the compound given via nasal route through nebulization was evaluated; hence the acute toxicity study and Multiple Ascending Dose Determination Study had been conducted before experimental study. Acute toxicity study of the compound showed that the drug is innocuous and very safe for therapeutic use with infinite LD 50 value. The dose determination study had showed that drug has the maximum therapeutic effect between the range of 500 mg−1 g. Thus, 500mg dose was selected to evaluate the immunomodulator effect of the drug.
At the end of the treatment, mice were anesthetized by using di-ethyl ether. The blood was collected from the retro-orbital plexus using heparinized capillary tubes and hematological tests were carried out. The WBC count was done by Turke's method,  RBC by Hayem's method,  and haemoglobin by Sahli's method.  The results are shown in [Figure 1], [Figure 2], [Figure 3], [Figure 4].
|Figure 1: Effect of hydroethanolic extract of Shirishadi (SE) on WBC Count in CP treated mice. All values are mean ± SEM, n = 6. ***P < 0.001 when compared with control group and, ###P < 0.001, when compared with cyclophosphamide (CP) treated group (Students t test). bP < 0.01, when compared with CP treated group (one way ANOVA)|
Click here to view
|Figure 2: Effect of hydroethanolic extract of Shirishadi compound on RBC count in CP treated mice. All values are mean ± SEM, n = 6. ***P < 0.001 when compared with control group and, ###P < 0.001, when compared with CP treated group (Students t test). bP < 0.01, when compared with CP treated group (one way ANOVA)|
Click here to view
|Figure 3: Effect of hydroethanolic extract of Shirishadi compound on Haemoglobin estimation in CP treated mice. All values are mean ± SEM, n = 6. ***P < 0.001 when compared with control group and, ###P < 0.001, when compared with CP treated group (Students t test). bP < 0.01, when compared with CP treated group (one way ANOVA)|
Click here to view
|Figure 4: Effect of hydroethanolic extract of Shirishadi compound on neutrophil adhesion test in CP treated mice. All values are mean ± SEM, n = 6. **P < 0.01 when compared with control group,|
###P < 0.001 when compared with CP treated group (Students t' test). bP < 0.01 when compared with CP treated group (one way ANOVA)
Click here to view
Neutrophil adhesion test
Total leukocyte counts (TLC) and differential leukocyte counts (DLC) were analyzed by fixing blood smears and staining with Field stain I and II- Leishman's stain. After initial counts, blood samples were incubated with 80 mg/ml of nylon fibers for 15 min at 37°C. The incubated blood samples were again analyzed for TLC and DLC. The product of TLC and % neutrophil gives neutrophil index (NI) of blood sample. 
Percent neutrophil adhesion was calculated as shown below
Neutrophil adhesion (%) = NI u - NI t × 100
NI u = Neutrophil index of untreated blood sample.
NI t = Neutrophil index of treated blood sample.
The data were expressed as the mean ± standard error of the means (SEM) and statistical analysis was carried out employing student's 't'- test and one-way analysis of variance (ANOVA) followed by Dunnett's multiple't' comparison test.
| Results|| |
Effectiveness against drug-induced immunosuppression
Administration of CP (30 mg/kg, i.p) produced a significant decrease in the Total Leukocyte Count from 6.2 ± 0.081 to 2.98 ± 0.214, RBC count from 5.02 ± 0.116 to 3.02 ± 0.152, and % hemoglobin from 15.49 ± 0.081 to 9.32 ± 0.153 (P < 0.01). This was found to be consistent with earlier studies which state that CP induces immune dysfunction through reactive intermediate-induced damage to the cells of the immune system.  Evaluation of effect of ethanolic extract of Shirishadi Compound on CP induced immunosuppression indicated good protection by increasing all the haematological parameters. WBC count, RBC count, and % hemoglobin values observed were better than untreated control groups [Figure 1], [Figure 2], [Figure 3].
Neutrophil adhesion test
This test is an indicative of the marginalization of phagocytic cells in the blood vessels, i.e. an indication of immunostimulation. The % neutrophil adhesion in control group animals was, 25.76 ± 1.585, in CP treated group it was 14.44 ± 1.08, in drug treated group it was 20.07 ± 1.043 [Figure 4]. The results of neutrophil adhesion test indicate that there was significant (P < 0.001) increase in neutrophil adhesion after administration of ethanol extract.
| Discussion|| |
Shirishadi compound is a polyherbal preparation consisting of Shirisha (Albezzia lebbeck), Nagarmotha (Cyprus rotundus) and Kantakari (Solanum surattense) prescribed in Ayurveda for several several diseases and its constituents have been investigated for different pharmacological properties. ,,,,,,,,,, Use of herbs for improving the overall resistance of body against common infections and pathogens has been a guiding principle of Ayurveda. The compound has been used and reported in many such formulations. However, there is no systematic study of its immunomodulatory activity. Hence in the present study, the immunomodulatory activity of ethanol extract of this polyherbal preparation was investigated.
The dynamic and complex nature of immune system can be better understood after immune challenge thus cyclophosphamide induced immune suppressive mice model is most reliable method for evaluation of immunomodulation effect. Haematological parameter such as Total WBC, RBC, Haemoglobin and neutrophil constitutes the key components of the immune system. A rise or fall in the number of these cells affects the health/immune constitution of the body as they are known to recognize the foreign antigens and mount an immune response.  Hence these parameters were chosen to study the immunomodulatory activity of the ethanol extract of Shirishadi compound.
The study affirms that ethanolic extract of the Shirishadi Compound is an effective immunomodulatory agent. The effectiveness of extract-treated animals in overcoming the side-effects of CP induced immunosuppression provides evidence for balancing and adaptogenic effectiveness of extract. The extract potentiated the non-specific immune response. This may be attributed to different phytoconstituents. Increase in percentage of neutrophil is attributed to marginalization of phagocytic cells i.e. improved defensive response under normal circumstances. Thus, with the result of this preliminary study it can be concluded that the Shirishadi compound holds the promise for being used as an immunostimulating agent.
| Conclusion|| |
The ethanolic extract of Shirishadi compound has protected the mice against CP induced immunosuppression indicating its profound immunostimulatory activity.
| References|| |
|1.||Acharya D, Shrivastava A. Indigenous Herbal Medicines: Tribal Formulations and Traditional Herbal Practices. 1 st ed. Jaipur (India): Aavishkar Publishers Distributor; 2008. |
|2.||VenkateshP, Mukerjee PK, Kumar NS, Bandyopadhyay A, Fukui H, Mizuguchi H et al. Anti-allergic activity of standardized extract of Albizia lebbeck with reference to catechin as a phytomarker. Immunopharmacol Immunotoxicol 2010;32:272-6. |
|3.||Tripathi, RM, Das PK. Studies on antiasthmatic and antianaphylactic activity of Albizia lebbeck. Indian J Pharmacol 1977;9:189‐94. |
|4.||Khare CP. Albizia lebbeck. Heidelberg, Friedrichshafen, editor. Indian Herbal Remedies: Rational Western Therapy, Ayurvedic and Other Traditional Usage, Botany. 1 st ed. Berlin, Heidelberg: Springer-Verlag Publisers; 2004. p. 30. |
|5.||Baruach CC, Gupta PP, Patnaik GK, Kulshreshtha DK, Dhawan BN. Anti anaphylactic and mast cell stabilizing activity of Albizia lebbeck. Indian Vet Med J 1997;2:127-32. |
|6.||Shahjahan M, Sabitha KE, Jainu M, Shyamala Devi CS. Effect of Solanum trilobatum against carbon tetrachloride induced hepatic damage in albino rats. Indian J Med Res 2004;120:194-8. |
|7.||Anonymous. Indian Herbal Pharmacopoeia. Vol. I. Jammu, Tawi: Indian Drug Manufacturers'Association, Mumbai and Regional Research Laboratory; 1998. p. 139-46. |
|8.||Gupta MB, Palit TK, Singh N, Bhargava KP. Pharmacological studies to isolate the active constituents from Cyperus rotundus possessing anti-inflammatory, anti-pyretic and analgesic activities. Indian J Med Res 1971;59:76-82. |
|9.||Nagulendran KR, Velavan S, Mahesh R. In vitro antioxidant activity and total polyphenolic content of Cyperus rotundus rhizomes. E-J Chem 2007;4:440-9. |
|10.||Anwikar S, Bhitre M. Study of the synergistic anti-inflammatory activity of Solanum xanthocarpum Schrad and Wendl and Cassia fistula Linn. Int J Ayurveda Res 2010;1:167-71. |
|11.||Gupta MP, Dutt S. Chemical examination of the seed of Solanum xanthocarpum II. constituents. J Indian Chem Soc 1938;15:95-100. |
|12.||Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. J Ethnopharmacol 1999; 66:205-10. |
|13.||Baumann F, Preiss R. Cyclophosphamide and related anticancer drugs. J Chromatogr. B Biomed Sci Appl 2001;764:173-92. |
|14.||Fleming RA. An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 1997; 17:146-54. |
|15.||Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytother Res 2004;18:805-9. |
|16.||Winkelstein A. Mechanisms of immunosuppression: Effects of cyclophosphamide on cellular immunity. Blood 1973; 41:273-84. |
|17.||Jayathirtha MG, Mishra SH. Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. Phytomedicine 2004;11:361-5. |
|18.||Dacie JV, Lewis SM. Practical Hematology. 11 th ed. Hong Kong: Longman Group Ltd.; 2001. p. 11-7. |
|19.||Easthan RD, Slade RR. Clinical Hematology. 7 th ed., vol. 5. London: Butter Work-Heinemann Ltd.; 1992. p. 82-105. |
|20.||Cavill I, Trevett D, Fisher J, Hoy T. The measurement of the total volume of red cells in man: A non-radioactive approach using biotin. Br J Haematol 1988;70:491-3. |
|21.||Wilkonson PC, Vane JK, Ferreria SH. Neutrophil adhesion test. Handbook of Experimental Pharmacology. 1 st ed., vol. 1. Berlin: Springer-Verlag; 1978. p. 109. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|This article has been cited by|
||Immunomodulatory Effects of Kuseonwangdogo-Based Mixed Herbal Formula Extracts on a Cyclophosphamide-Induced Immunosuppression Mouse Model
| ||Joo Wan Kim,Jae-Suk Choi,Du Jin Seol,Jai Jun Choung,Sae Kwang Ku |
| ||Evidence-Based Complementary and Alternative Medicine. 2018; 2018: 1 |
|[Pubmed] | [DOI]|
||In vitro and in vivo immunomodulatory potential of Pedicularis longiflora and Allium carolinianum in alloxan-induced diabetes in rats
| ||Mohd. Iqbal Yatoo,Umesh Dimri,Arumugam Gopalakrishnan,Archana Saxena,Sarfaraz Ahmad Wani,Kuldeep Dhama |
| ||Biomedicine & Pharmacotherapy. 2018; 97: 375 |
|[Pubmed] | [DOI]|
||Phytotrapy of cyclophosphamide-induced immunosuppression
| ||Kobra Shirani,Faezeh Vahdati Hassani,Kamal Razavi-Azarkhiavi,Somayeh Heidari,Bamdad Riahi Zanjani,Gholamreza Karimi |
| ||Environmental Toxicology and Pharmacology. 2015; |
|[Pubmed] | [DOI]|